Compare outcomes in children with and without CBP during sepsis
Part of Infections clinical trials.
This study looks at children with sepsis to see how outcomes differ between those who receive a specific blood-cleansing treatment (CBP) and those who do not. Results may help clinicians choose treatments that lead to better recovery in sick children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 29 days old and 18 years old
- A doctor has diagnosed your child with sepsis
- Your child needs blood purification (a blood-cleansing treatment) for sepsis
- Your child has not had an ICU (PICU) stay shorter than 24 hours
- Your child does not have active bleeding, including bleeding in the brain
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a blood-cleaning treatment in children with early, serious sepsis to see if it helps organs recover. It’s meant for children who are very sick soon after sepsis starts.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This study looks at how sepsis (a severe infection that can affect the whole body) affects children after they leave the intensive care unit. It compares children who had sepsis to those with other critical illnesses to understand long-term health.
This study looks at a specific blood protein level in children from birth to age 17. It compares healthy children and those with sepsis to see if the protein changes during infection.
This trial compares giving a long, continuous infusion versus standard short infusions of certain antibiotics (beta-lactams) to children with sepsis in intensive care. The goal is to find which method works better and is safer.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.